By using a small molecular inhibitor of AXL in vivo, it was demonstrated that AXL inhibition significantly reduced the homing of the osteosarcoma cells into the lungs, diminishing the number of pulmonary metastases [120,121]. The gene discussed is AXL; the disease is osteosarcoma.